loader
Please Wait
Applying Filters...
menu
    • menu

    DMF Submitted for Lisdexamfetamine Dimesylate API services provided by Noramco

    Virtual BoothMenuNoramco
    DMF Submitted for Lisdexamfetamine Dimesylate API

    Uploaded: 2018
    News
    Diversifying the Supply of Raw Materials

    12 Jun 2024

    // PRESS RELEASE

    Noramco Aligns with Purisys and Halo Pharma to Create Noramco Group

    15 Mar 2024

    // PRESS RELEASE

    Noramco Announces the Acquisition of the Cambrex Drug Product Business Unit

    02 Nov 2023

    // PRESS RELEASE

    DATA COMPILATION
    #PharmaFlow

    Normaco

    Contact Supplier

    Website

    DCAT Week

    Attending

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    radio-compass-blog/fda-s-first-generic-approvals-slump-21-in-2024-novartis-top-seller-entresto-cancer-blockbuster-tasigna-lead-2024-patent-cliff
    Xls

    CATEGORY PAGE
    Menu

    Noramco

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    Key Products KEY PRODUCTS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    PC100645